# An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?

> Research article (Health Policy, 2018) · cited 27× · AI/ML

**Wikidata**: [openalex:W2801738355](https://www.wikidata.org/wiki/openalex:W2801738355)  
**Source**: https://4ort.xyz/entity/an-exploratory-case-study-of-the-impact-of-expanding-cost-effectiveness-analysis-for-second-line-nivolumab-for-patients-